Cell Cycle News & Views
Cyclin-dependent kinase 4/6 inhibition in cancer therapy
Downloads and Tools
Article PDF
412.26 KB PDF document
XML File
Full Text XML
18.35 KB XML Document
This is an open access article.
Print this page
Email this page
Article Citation
RIS MARC (XML) FULL CITATION
Share on Facebook
Page 3913
http://dx.doi.org/10.4161/cc.22390
Authors: Neil Johnson and Geoffrey I. Shapiro
View affiliations
Cell Cycle News & Views to:
JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ES Knudsen. Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors. Cell Cycle 2012; 11: 2756-61
PMID: 22767154 DOI: 10.4161/cc.21195
and
AK McClendon, JL Dean, DB Rivadeneira, JE Yu, CA Reed, E Gao, JL Farber, T Force, WJ Koch, ES Knudsen. CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy. Cell Cycle 2012; 11: 2747-55
PMID: 22751436 DOI: 10.4161/cc.21127
Received: September 4, 2012; Accepted: September 17, 2012; Published Online: October 3, 2012
Preview:
Advertisements
